Report
Patient advocates and some experts raise alarm over perceived risks of a Neurocrine drug
STAT reports that the concerns involve a rare disease drug sold by Neurocrine Biosciences.
TLDR
STAT reports growing alarm among patient advocates and some experts over the perceived risks of a rare disease drug sold by Neurocrine Biosciences.
Combined views
2.5K
1 Source, first seen ago
likes